References
- Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR-2):1–28. PMID:23515099
- Patton ME, Stephens D, Moore K, MacNeil JR. Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine—advisory committee on immunization practices, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(19):509. doi:10.15585/mmwr.mm6619a6. PMID:28520709
- Basta NE, Mahmoud AAF, Wolfson J, et al. Immunogenicity of a meningococcal B vaccine during a university outbreak. N Engl J Med. 2016;375(3):220–228. doi:10.1056/NEJMoa1514866. PMID:27468058
- Atkinson B, Gandhi A, Balmer P. History of meningococcal outbreaks in the United States: implications for vaccination and disease prevention. Pharmacotherapy. 2016;36(8):880–892. doi:10.1002/phar.1790.
- Fiorito TM, Bornschein S, Mihalakos A, et al. Rapid response to a college outbreak of meningococcal serogroup B disease: Nation’s first widespread use of bivalent rLP2086 vaccine. J Am Coll Health. 2017;65(4):294–296. doi:10.1080/07448481.2017.1285772. PMID:28121236
- Breakwell L, Vogt TM, Fleming D, et al. Understanding factors affecting university a students’ decision to receive an unlicensed serogroup B meningococcal vaccine. J Adolesc Health. 2016;59(4):457–464. doi:10.1016/j.jadohealth.2016.06.004. PMID:27523976
- MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the advisory committee on immunization practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(41):1171–1176. doi:10.15585/mmwr.mm6441a3. PMID:26492381